EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

BREAST CANCER

Mansi S. Pandit*, Akshay B. More, Shreegita R. Jadhav and Archana R. Gavit

ABSTRACT

The following article is based on the investigation of different dimension. Based on breast cancer and factors (risk and genetic) associated with it. Staging, detection, treatment and diagnosis of breast cancer. Breast cancer is the most frequent malignancy in women worldwide all over 25% death is due to cancer. 14% arise from breast cancer. Breast cancer is an heterogenous disease an molecular level. Which is curable in 70-80% of patient cancer associate with early stage and non-metastatic. This molecule level cancer include activation of human epidermal growth factor receptor 2, activation of harmone BRCA receptor. Treatment is based on according molecular subtype with different in strategies. This is huge impact on women physical and mental health. Breast cancer‟s etiology is unknown, treatment associated with identification of risk factors. Normal surgery, radiation therapy and chemotherapy allow a good prognosis where screening measure are in place.

Keywords: Cancer, Breast Cancer, Risk factor, Staging, Screening.

[Full Text Article] [Download Certificate]